News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
IO/IO vs IO/TKI in the Treatment of Intermediate Risk RCC at the World GU Conference
Photo from World GU Conference/X
Aug 3, 2024, 17:29

IO/IO vs IO/TKI in the Treatment of Intermediate Risk RCC at the World GU Conference

World GU Conference shared on X:

“Two kidney cancer experts head spin their way through the debate on IO/IO vs IO/TKI in the Treatment of Intermediate Risk RCC.

Let’s watch Drs. David McDermott vs Rana McKay pop and lock this debate!”

Source: World GU Conference/X

cancer David McDermott IO kidney cancer OncoDaily Oncology Rana McKay RCC TKI World GU Conference
Special Coverage
Insight
Jan 15, 2025, 18:32
MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening
Insight
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Blog
Jan 15, 2025, 18:25
Discussion on advancing the Global Cancer Fund at The White House - ASCO
Blog
Jan 15, 2025, 18:19
Antonio Passaro: COCOON study meets primary endpoint
Blog
Jan 15, 2025, 17:58
Felice Gorordo: The White House's round table on the creation of the Global Cancer Fund
Insight
Jan 15, 2025, 17:48
ESO announced the mentorship pairings for 2025
Insight
Jan 15, 2025, 17:38
Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI
Blog
Jan 15, 2025, 17:37
Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine
Blog
Jan 15, 2025, 17:33
Exploring the Future of HR+/HER2- MBC Treatment – Live Webinar by SPCC
Insight
Jan 15, 2025, 17:27
Integration of Generative AI into Radiation Therapy practice
Insight
Jan 15, 2025, 17:26
Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas
Insight
Jan 15, 2025, 17:19
Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al